C. Gregory Peters
Stock Analyst
(n/a)
# 4,647
Out of 4,655 analysts
190
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by C. Gregory Peters
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALL The Allstate Corporation | Maintains: Strong Buy | $205 → $220 | $184.15 | +19.47% | 23 | Oct 4, 2024 | |
| KMPR Kemper | Maintains: Strong Buy | $70 → $75 | $62.43 | +20.13% | 12 | Aug 8, 2024 | |
| BRO Brown & Brown | Maintains: Outperform | $95 → $110 | $104.17 | +5.60% | 10 | Jul 25, 2024 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $86.33 | +21.63% | 10 | Jun 7, 2024 | |
| BWIN The Baldwin Insurance Group | Reiterates: Strong Buy | $40 → $45 | $45.29 | -0.64% | 1 | May 22, 2024 | |
| HIG The Hartford Financial Services Group | Reiterates: Outperform | $100 → $120 | $110.09 | +9.00% | 6 | Apr 1, 2024 | |
| WTW Willis Towers Watson | Reiterates: Outperform | $295 → $315 | $299.30 | +5.25% | 9 | Mar 28, 2024 | |
| CB Chubb | Maintains: Strong Buy | $270 → $285 | $277.41 | +2.74% | 8 | Feb 1, 2024 | |
| TRV The Travelers Companies | Maintains: Strong Buy | $220 → $245 | $245.64 | -0.26% | 7 | Jan 22, 2024 | |
| ACIC American Coastal Insurance | Initiates: Outperform | $15 | $12.30 | +21.95% | 1 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $36 → $40 | $43.70 | -8.47% | 7 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $242.72 | - | 19 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $280.40 | - | 18 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $455 → $460 | $350.97 | +31.07% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $255 → $260 | $275.48 | -5.62% | 8 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $29 → $30 | $34.50 | -13.04% | 8 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $205 → $210 | $219.10 | -4.15% | 16 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $40 → $33 | $65.61 | -49.70% | 5 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $364.42 | - | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $10.92 | - | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $140.65 | - | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $157.21 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $67 | $104.71 | -36.01% | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.71 | - | 4 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $37.35 | - | 1 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.86 | - | 4 | Feb 1, 2021 |
The Allstate Corporation
Oct 4, 2024
Maintains: Strong Buy
Price Target: $205 → $220
Current: $184.15
Upside: +19.47%
Kemper
Aug 8, 2024
Maintains: Strong Buy
Price Target: $70 → $75
Current: $62.43
Upside: +20.13%
Brown & Brown
Jul 25, 2024
Maintains: Outperform
Price Target: $95 → $110
Current: $104.17
Upside: +5.60%
HealthEquity
Jun 7, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $86.33
Upside: +21.63%
The Baldwin Insurance Group
May 22, 2024
Reiterates: Strong Buy
Price Target: $40 → $45
Current: $45.29
Upside: -0.64%
The Hartford Financial Services Group
Apr 1, 2024
Reiterates: Outperform
Price Target: $100 → $120
Current: $110.09
Upside: +9.00%
Willis Towers Watson
Mar 28, 2024
Reiterates: Outperform
Price Target: $295 → $315
Current: $299.30
Upside: +5.25%
Chubb
Feb 1, 2024
Maintains: Strong Buy
Price Target: $270 → $285
Current: $277.41
Upside: +2.74%
The Travelers Companies
Jan 22, 2024
Maintains: Strong Buy
Price Target: $220 → $245
Current: $245.64
Upside: -0.26%
American Coastal Insurance
Jan 17, 2024
Initiates: Outperform
Price Target: $15
Current: $12.30
Upside: +21.95%
Dec 12, 2023
Maintains: Strong Buy
Price Target: $36 → $40
Current: $43.70
Upside: -8.47%
Dec 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $242.72
Upside: -
Dec 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $280.40
Upside: -
Nov 20, 2023
Maintains: Strong Buy
Price Target: $455 → $460
Current: $350.97
Upside: +31.07%
Nov 2, 2023
Maintains: Outperform
Price Target: $255 → $260
Current: $275.48
Upside: -5.62%
Oct 30, 2023
Maintains: Outperform
Price Target: $29 → $30
Current: $34.50
Upside: -13.04%
Oct 20, 2023
Maintains: Outperform
Price Target: $205 → $210
Current: $219.10
Upside: -4.15%
Jul 7, 2023
Downgrades: Outperform
Price Target: $40 → $33
Current: $65.61
Upside: -49.70%
Oct 31, 2022
Downgrades: Underperform
Price Target: n/a
Current: $364.42
Upside: -
Oct 20, 2022
Initiates: Market Perform
Price Target: n/a
Current: $10.92
Upside: -
Sep 23, 2022
Initiates: Market Perform
Price Target: n/a
Current: $140.65
Upside: -
Jun 7, 2022
Initiates: Market Perform
Price Target: n/a
Current: $157.21
Upside: -
Feb 7, 2022
Maintains: Outperform
Price Target: $60 → $67
Current: $104.71
Upside: -36.01%
Aug 12, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $11.71
Upside: -
Feb 19, 2021
Initiates: Market Perform
Price Target: n/a
Current: $37.35
Upside: -
Feb 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.86
Upside: -